These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6491335)

  • 1. Immunological status in acute viral hepatitis and fulminant hepatic failure.
    Singh NK; Goyal AK; Srivastava PK; Gupta RM; Tripathi KK
    J Indian Med Assoc; 1984 Aug; 82(8):281-3. PubMed ID: 6491335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulins in acute hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Lopez S
    Gastroenterology; 1982 Oct; 83(4):944. PubMed ID: 7106526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protracted viral hepatitis (hepatitis virusalis forma prolongata) in children].
    Jung H
    Pediatr Pol; 1979 Mar; 54(3):249-53. PubMed ID: 450496
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-immunological aspects of chronic hepatitis of viral etiology].
    Tel'nykh IuV; Khavinson VKh; Morozov VG; Ivashkin VT
    Ter Arkh; 1984; 56(2):83-6. PubMed ID: 6710414
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical significance of antiphospholipid antibodies in fulminant hepatic failure.
    Tada K; Akamatsu K; Konno T; Ohuchi T; Ohkubo K; Hayama K; Yamamoto S; Wakabayashi T; Ohta Y
    Hepatogastroenterology; 1995 Feb; 42(1):27-30. PubMed ID: 7782030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral markers of acute hepatitis: a study in 291 children and adults in Chile].
    Velasco M; Puelma E; Katz R; Zacarías J
    Rev Med Chil; 1982 Jun; 110(6):542-6. PubMed ID: 6819623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum inhibition factor in acute viral hepatitis].
    Berg PA; Brattig N
    Leber Magen Darm; 1984 Nov; 14(6):261-9. PubMed ID: 6334798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of fulminant hepatic failure in previously unrecognized HBsAg carriers with acute hepatitis independent of etiology.
    Chu CM; Liaw YF
    Infection; 2005 Jun; 33(3):136-9. PubMed ID: 15940414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pancreatitis in patients with fulminant hepatic failure.
    Parbhoo SP; Welch J; Sherlock S
    Gut; 1973 May; 14(5):428. PubMed ID: 4716531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunoglobulins of the duodenal secretion proper in gastroduodenitis with a past history of viral hepatitis].
    Makos' RP; Denisiuk VG
    Klin Med (Mosk); 1981 Oct; 59(10):73-5. PubMed ID: 7311417
    [No Abstract]   [Full Text] [Related]  

  • 14. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
    Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
    Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [State of immunity of patients with chronic viral diseases of the liver].
    Dzhalalova VA; Khazanov AI; Ivlev AS; Polovoĭ AM; Skriabina EG
    Voen Med Zh; 1986 Jan; (1):36-8. PubMed ID: 3962217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the serum protein picture in viral hepatitis. III. Evaluation of immunoglobulins].
    Borsotti M; De Philippis C; Leoncini F; Mazzotta F; Paci F; Piazza E; Spadolini MP
    Quad Sclavo Diagn; 1980 Dec; 16(4):402-11. PubMed ID: 7244111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatic failure in northern Brazil: morphological, immunohistochemical and pathogenic aspects of Lábrea hepatitis and yellow fever.
    Dias LB; Alves VA; Kanamura C; Oikawa RT; Wakamatsu A
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):831-9. PubMed ID: 17568643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant hepatic failure: etiology, viral markers and outcome.
    Bendre SV; Bavdekar AR; Bhave SA; Pandit AN; Chitambar SD; Arankalle VA
    Indian Pediatr; 1999 Nov; 36(11):1107-12. PubMed ID: 10745331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis.
    Gitlin N
    Am J Gastroenterol; 1982 Jan; 77(1):2-4. PubMed ID: 6801971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.